Literature DB >> 26860935

A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.

Atsuko Kasajima1, José Cameselle-Teijeiro2, Lourdes Loidi3, Yoshio Takahashi4, Noriaki Nakashima4, Satoko Sato5, Fumiyoshi Fujishima5, Mika Watanabe5, Tadao Nakazawa6, Hiroshi Naganuma7, Tetsuo Kondo6, Ryohei Kato6, Hironobu Sasano5,8.   

Abstract

Neuroendocrine tumors of the thyroid gland are generally considered to derive from parafollicular endocrine cells (C cells) and are generally referred to as medullary thyroid carcinomas (MTC). Calcitonin secretion is almost always detected in MTC and a prerequisite for both clinical and pathological diagnosis. Thyroid neuroendocrine tumors without any apparent calcitonin secretion reflect a diagnostic dilemma because non-calcitonin-producing MTCs have virtually not been characterized. Here, we report a case of primary thyroid neuroendocrine tumors lacking calcitonin secretion or expression. The tumor cells expressed cytokeratins, chromogranin A, and synaptophysin, all of which were consistent with epithelial and neuroendocrine differentiation. Thyroid transcription factor-1 paired box gene 8, and carcinoembryonic antigen were also immunohistochemically detected, consistent with its thyroid origin. However, the tumor was negative for calcitonin both by immunohistochemistry and in situ hybridization, hence, not meeting the definition of MTC. Despite the loss of calcitonin expression, immunoreactivity for the calcitonin-gene-related peptide was detected in the tumor. Somatic gene mutations of RET, H-RAS, K-RAS, or BRAF were not detected in this case. A limited number of calcitonin non-producing thyroid neuroendocrine tumors are available in the scientific literature available in English, and its etiology and clinical manifestations remain largely unknown. Our case, along with the rare, previously reported cases, suggests that calcitonin non-producing neuroendocrine tumors of the thyroid gland are most likely derived from C cells, but should be differentiated from ordinary MTCs.

Entities:  

Keywords:  Calcitonin; Medullary carcinoma; Neuroendocrine tumor; Thyroid gland

Mesh:

Substances:

Year:  2016        PMID: 26860935     DOI: 10.1007/s12022-016-9416-9

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  22 in total

1.  Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.

Authors:  Victoriya S Chernyavsky; Saima Farghani; Tomer Davidov; Ly Ma; Nicola Barnard; Louis F Amorosa; Stanley Z Trooskin
Journal:  Thyroid       Date:  2011-02       Impact factor: 6.568

2.  Immunoreactive somatostatin and calcitonin in pulmonary neuroendocrine tumor.

Authors:  T Sano; H Saito; R Yamasaki; K Hamaguchi; K Ooiwa; T Shimoda; E Hosoi; S Saito; K Hizawa
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

3.  Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.

Authors:  X Matias-Guiu; J LaGuette; A M Puras-Gil; J Rosai
Journal:  Am J Surg Pathol       Date:  1997-07       Impact factor: 6.394

4.  Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.

Authors:  Michelle S Hirsch; William C Faquin; Jeffrey F Krane
Journal:  Mod Pathol       Date:  2004-06       Impact factor: 7.842

5.  Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia.

Authors:  E D Williams; B J Ponder; R K Craig
Journal:  Clin Endocrinol (Oxf)       Date:  1987-07       Impact factor: 3.478

6.  Identification of calcitonin and calcitonin gene-related peptide messenger ribonucleic acid in medullary thyroid carcinomas by hybridization histochemistry.

Authors:  J D Zajac; J Penschow; T Mason; G Tregear; J Coghlan; T J Martin
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

7.  C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.

Authors:  Tadao Nakazawa; José Cameselle-Teijeiro; João Vinagre; Paula Soares; Emmanuel Rousseau; Catarina Eloy; Manuel Sobrinho-Simões
Journal:  Int J Surg Pathol       Date:  2014-03-04       Impact factor: 1.271

Review 8.  Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system.

Authors:  Long-Chuan Yu; Jun-Feng Hou; Feng-Hua Fu; Ying-Xin Zhang
Journal:  Neurosci Biobehav Rev       Date:  2009-03-24       Impact factor: 8.989

Review 9.  Primary paraganglioma of thyroid gland: a clinicopathologic and immunohistochemical analysis of three cases with a review of the literature.

Authors:  Bao-Hua Yu; Wei-Qi Sheng; Jian Wang
Journal:  Head Neck Pathol       Date:  2013-08-13

10.  Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.

Authors:  Daisuke Nonaka; Yunjia Tang; Luis Chiriboga; Michael Rivera; Ronald Ghossein
Journal:  Mod Pathol       Date:  2007-12-14       Impact factor: 7.842

View more
  5 in total

1.  Calcitonin-negative neuroendocrine tumor of the thyroid with metastasis to liver-rare presentation of an unusual tumor: A case report and review of literature.

Authors:  Huai-Jie Cai; Han Wang; Nan Cao; Bin Huang; Fan-Lei Kong; Li-Ren Lu; Ya-Yuan Huang; Wei Wang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

2.  Oncocytic Variant of Medullary Thyroid Carcinoma: A Rare Case of Sporadic Multifocal and Bilateral RET Wild-Type Neoplasm with Revision of the Literature.

Authors:  Gian Luca Rampioni Vinciguerra; Niccolò Noccioli; Claudia Cippitelli; Angelo Minucci; Ettore Capoluongo; Armando Bartolazzi
Journal:  Rare Tumors       Date:  2016-12-20

Review 3.  Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers.

Authors:  José Manuel Cameselle-Teijeiro; Catarina Eloy; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2020-07-06       Impact factor: 3.943

Review 4.  An encapsulated oncoytic neoplasm of follicular origin of thyroid, expressing neuroendocrine markers. A case report and literature review.

Authors:  Marcello Filotico; Francesca Plutino
Journal:  Pathologica       Date:  2021-12

5.  Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer.

Authors:  Joseph A Chorny; John J Orrego; José Manuel Cameselle-Teijeiro
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.